NCT00005798 - Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | Biotech Hunter

Enrollment

209

Participants

Timeline

Start Date

July 31, 1995

Primary Completion Date

August 31, 2001

Study Completion Date

July 31, 2007

Conditions

Breast Cancer

Interventions

DRUG

Carboplatin

Carboplatin will be given at a dose of 267 mg/m2 in D5 W IV over one hour daily on days -6, -5, and -4. (Total dose 800 mg/m2)

DRUG

Cyclophosphamide

Cyclophosphamide will be given at a dose of 2000 mg/m2 in NS IV over one hour daily on days -6, -5, and -4. (Total dose 6000 mg/m2)

DRUG

Thiotepa

Thiotepa will be given at a dose of 167 mg/m2 in NS IV over one hour daily on days -6, -5, and -4. (Total dose 500 mg/m2 )

Trial Locations (3)

Halifax Medical Center, Daytona Beach

Florida Cancer Specialists, Fort Myers

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER